home / stock / prct / prct news


PRCT News and Press, PROCEPT BioRobotics Corporation From 11/06/22

Stock Information

Company Name: PROCEPT BioRobotics Corporation
Stock Symbol: PRCT
Market: NASDAQ
Website: procept-biorobotics.com

Menu

PRCT PRCT Quote PRCT Short PRCT News PRCT Articles PRCT Message Board
Get PRCT Alerts

News, Short Squeeze, Breakout and More Instantly...

PRCT - PROCEPT BioRobotics Corporation (PRCT) Q3 2022 Earnings Call Transcript

PROCEPT BioRobotics Corporation (PRCT) Q3 2022 Earnings Call Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Bacso – Vice President-Investor Relations Reza Zadno – Chief Executive Officer Kevin Waters – Senior Vice Presi...

PRCT - PROCEPT BioRobotics Corporation 2022 Q3 - Results - Earnings Call Presentation

The following slide deck was published by PROCEPT BioRobotics Corporation in conjunction with their 2022 Q3 earnings call. For further details see: PROCEPT BioRobotics Corporation 2022 Q3 - Results - Earnings Call Presentation

PRCT - Procept GAAP EPS of -$0.51 misses by $0.03, revenue of $20.35M beats by $3.12M

Procept press release ( NASDAQ: PRCT ): Q3 GAAP EPS of -$0.51 misses by $0.03 . Revenue of $20.35M (+134.7% Y/Y) beats by $3.12M . U.S. system and rental revenue of $9.8M, an increase of 95% compared to the prior year period. U.S. handpiece and co...

PRCT - PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financia...

PRCT - PROCEPT BioRobotics a buy at Truist on disrupting BPH treatment market

Truist has initiated PROCEPT BioRobotics ( NASDAQ: PRCT ) with a buy rating saying the company's AquaBeam Robotic System can potentially disrupt the market for the treatment of benign prostatic hyperplasia (BPH). The firm has a $58 price target (~35% upside based on M...

PRCT - PROCEPT BioRobotics to Report Third Quarter 2022 Financial Results on November 3, 2022

REDWOOD CITY, Calif., Oct. 12, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will repor...

PRCT - Procept Biorobotics announces $52M debt refinancing

Procept BioRobotics ( NASDAQ: PRCT ) has entered into a new five-year $52M loan arrangement with CIBC Innovation Banking. The proceeds were used to retire a $50M debt facility with the company’s existing lender. The new term loan includes a final...

PRCT - PROCEPT BioRobotics Announces $52 Million Debt Refinancing

REDWOOD CITY, Calif., Oct. 10, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that it has e...

PRCT - Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2022 Update

Summary Stanley Druckenmiller’s 13F portfolio value decreased from $2.65B to $1.63B this quarter. Duquesne added Eli Lilly and CrowdStrike while reducing Microsoft, Freeport-McMoRan, and Teck Resources. They also dropped Amazon.com. The top three positions are at ~34% o...

PRCT - Providence announces national contract for PROCEPT Biorobotics Aquabeam Systems

Surgical robotics firm PROCEPT BioRobotics ( NASDAQ: PRCT ) and Providence announced on Monday a multi-system, national contract to acquire AquaBeam Robotic Systems. The company through the acquisition hopes to partner with health systems, such as Providence to support th...

Previous 10 Next 10